Abbott Laboratories (ABT)

88.25
NYSE : Health Technology
Prev Close 91.40
Day Low/High 88.23 / 91.33
52 Wk Low/High 61.61 / 100.00
Avg Volume 10.60M
Exchange NYSE
Shares Outstanding 1.77B
Market Cap 161.67B
EPS 2.10
P/E Ratio 44.15
Div & Yield 1.44 (1.47%)
Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Good Medicine Makes for 3 Good Charts

Good Medicine Makes for 3 Good Charts

Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.

Midday Report: Morgan Stanley Boosts Financials; IBM Drags Dow Into Red

Midday Report: Morgan Stanley Boosts Financials; IBM Drags Dow Into Red

Earnings take center stage again with a disappointment from IBM and a better-than-expected performance from Morgan Stanley dividing markets.

Stocks That Are Changing Direction

Stocks That Are Changing Direction

These charts are showing bullish or bearish reversals.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Abbott Labs Is Set to Go Substantially Higher

Abbott Labs Is Set to Go Substantially Higher

Here are the levels to watch and act on.

Abbott Labs downgraded at BMO

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

These stocks are indicating a change in direction.

A Play on Intel's Breakdown

A Play on Intel's Breakdown

With trend favoring the bears, I'm favoring a bearish call spread.

Abbott Labs: Diagnosing Growth in 2017

Abbott Labs: Diagnosing Growth in 2017

ABT could be on course for 10% earnings growth this year, but will investors reward the company with a higher share price?

Dump These 5 'Toxic Stocks' Before the New Year

Dump These 5 'Toxic Stocks' Before the New Year

Start 2017 on the right foot by selling your holdings in these five stocks.

Abbott Laboratories Can Merge With St. Jude Medical: FTC

Abbott Laboratories Can Merge With St. Jude Medical: FTC

The Federal Trade Commission says Abbott Laboratories can proceed with its proposed $25 billion acquisition of St. Jude Medical.

Top 5 Dividend Stocks to Buy Now for 2017

Top 5 Dividend Stocks to Buy Now for 2017

Here is a look at some stocks that are poised for excellent dividend returns in 2017.

Abbott Labs Is Likely to See Further Weakness

Abbott Labs Is Likely to See Further Weakness

Look for ABT's declining trend to continue a while longer.

The Good, the Bad and the Ugly

"You see, in this world there's two kinds of people, my friend: Those with loaded guns and those who dig. You dig." -- Blondie in "The Good, the Bad and the Ugly." I did very little today.   Markets were higher from the get-go and seemed "stuck" nea...

Abbott Labs Shares Climb on Better-Than-Expected Earnnigs

Abbott Labs Shares Climb on Better-Than-Expected Earnnigs

Shares of the medical-device giant were climbing after unveiling strong earnings.

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

Jim Cramer: St. Jude Battery Woes Big But Not a Dealbreaker

St. Jude's warning about battery risks in its implanted heart devices are big but will likely not disrupt its deal with Abbott Labs.

Closing Bell: LionsGate's 'Blair Witch' Set to Own Box Office; U.S. Stocks Fall

Closing Bell: LionsGate's 'Blair Witch' Set to Own Box Office; U.S. Stocks Fall

U.S. stocks ended Friday's session lower as a crude oil selloff pressures the energy sector and nerves over next week's Federal Reserve meeting peak.

4 Market Segments to Avoid

4 Market Segments to Avoid

These sectors are full of high-priced, low-growth stocks.

Cramer: The Answer to This Market: Part 1

Cramer: The Answer to This Market: Part 1

The leadership is quite stark.

Charts Emit a Yellow 'Caution' Signal

Charts Emit a Yellow 'Caution' Signal

The signs that have warned of a possible market reversal only have become more extreme.

Trending Tickers: SWN, ABT, AAL, UAL, EW

Oil began to rebound Wednesday from steep declines earlier this week.

Traders, Here's Your 'Short' Notice

Traders, Here's Your 'Short' Notice

They should wait until the rally appears to be running out of steam in order to go in on the short side.

Cramer: Worst May Be Over for Embattled Pharma

The M&A activity is an incredible and a welcome sign.

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer: I’m a Huge Backer of Abbott Labs CEO Miles White

Jim Cramer is bullish on Abbott Laboratories' acquisition of St. Jude Medical.

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. Stocks Slip on Sluggish GDP; Ford Posts Record Profit

U.S. stocks dropped on Thursday, as first quarter gross domestic product came in weaker than expected.